Advertisement

Serial Evoked Potentials and Disease Progression in Multiple Sclerosis

  • A. Ghezzi
  • E. Mazzalovo
  • D. Caputo
  • M. Zaffaroni
  • R. Montanini
Conference paper

Abstract

Cerebral evoked potentials (EPs) have been included among the tests for diagnosis of multiple sclerosis (MS) as methods for paraclinical demonstration of multifocal CNS involvement [1]. Their use has also been suggested in MS monitoring in order to evaluate disease progression and treatment efficacy objectively [2–4]. In this point the role of EPs is not well established and results are inconclusive [5–10].

Keywords

Multiple Sclerosis Stable Patient Functional Scale Potential Recording Definite Multiple Sclerosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Poser CM, Paty DW, Scheinberg L et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for reseach protocols. Ann Neurol 13:227–231PubMedCrossRefGoogle Scholar
  2. 2.
    Becker WJ, Richards IM (1984) Serial pattern shift visual evoked potentials in multiple sclerosis. Canad J Neurol Sci 11:53–59PubMedGoogle Scholar
  3. 3.
    Likosky W, Elmore RS (1982) Exacerbation detection in multiple sclerosis by clinical and evoked potentials techniques: a preliminary report. In: Courjon J, Mauguière F, Revol M (eds) Clinical applications of evoked potentials in neurolgy. Raven, New York, pp 535–540Google Scholar
  4. 4.
    Walsh JC, Garrick R, Cameron J, McLeod JG (1982) Evoked potential changes in clinically definite multiple sclerosis: a two year follow up study. J Neurol Neurosurg Psychiatry 45:494–500PubMedCrossRefGoogle Scholar
  5. 5.
    Kjaer M (1982) The values of sequential evoked potential recordings in multiple sclerosis. In: Courjon J, Mauguière F, Revol M (eds) Clinical application of evoked potentials in Neurology. Raven, New York, pp 567–Google Scholar
  6. 6.
    Cohen SN, Syndulko K, Hansh E, Tourtellotte WW, Potvin AR (1982) Variability of serial testing of visual evoked potentials in patients with multiple sclerosis. In: Courjon J, Mauguière F, Revol M (eds) Clinical applications of evoked potentials in Neurology. Raven, New York, pp 559–Google Scholar
  7. 7.
    Gambi D, Rossini PM, Marchionno L, Iarlori T, Finarelli A, Pirchio M (1982) Multimodal evoked potentials in multiple sclerosis: basal and follow-up data. In: Courjon J, Mauguière F, Revol M (eds) Clinical applications of evoked potentials in Neurology. Raven, New York, P 551Google Scholar
  8. 8.
    De Weerd AW, Jokman GJ (1982) Changes in visual and somatosensory evoked potentials in patients with multiple sclerosis. In: Courjon J, Mauguière F, Revol M (eds) Clinical applications of evoked potentials in Neurology. Raven, New York, pp 527–534Google Scholar
  9. 9.
    Aminoff MJ, Davis SL, Panitch HS (1984) Serial evoked potential studies in patients with definite multiple sclerosis. Arch Neurol 41:1197–1202PubMedGoogle Scholar
  10. 10.
    Davis SL, Aminoff MJ, Panitch HS (1985) Clinical correlations of serial somatosensory evoked potentials in MS. Neurology 35:359–365PubMedGoogle Scholar
  11. 11.
    Ghezzi A, Zaffaroni M, Caputo D, Montanini R, Cazzullo CL (1986) Evaluation of evoked potentials and lymphocyte subsets as possible markers of multiple sclerosis: one year follow up of 30 patients. J Neurol Neurosurg Psychiatry 49:913–919PubMedCrossRefGoogle Scholar
  12. 12.
    Confavreux C, Mauguière F, Courjon J, Aimard G, Devic M (1982) Course of visual evoked potentials in multiple sclerosis: eletroclinical correlations and patophysiological considerations in 25 patients. In: Courjon J, Mauguière F. Revol M (eds) Clinical applications of evoked potentials in Neurology. Raven, New York, pp 541–550Google Scholar
  13. 13.
    Kurtzke JF (1965) Further notes on disability evaluation in multiple sclerosis with scale modification. Neurology (Minneap) 15:654–661Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • A. Ghezzi
    • 1
  • E. Mazzalovo
    • 2
  • D. Caputo
    • 1
  • M. Zaffaroni
    • 1
  • R. Montanini
    • 2
  1. 1.Centro Studi Sclerosi MultiplaOspedale di Gallarate, Université di MilanoItaly
  2. 2.Divisione NeurologicaOspedale di GallarateItaly

Personalised recommendations